Literature DB >> 24187448

Virus entry mediated by hepatitis B virus envelope proteins.

John M Taylor1.   

Abstract

Hepatitis B virus (HBV), a major cause of human liver disease worldwide, encodes three envelope proteins needed for the attachment and entry of the virus into susceptible host cells. A second virus, hepatitis delta virus, which is known to enhance liver disease in HBV infected patients, diverts the same HBV envelope proteins to achieve its own assembly and infection. In the lab, lentiviral vectors based on human immunodeficiency virus type 1 can be assembled using the HBV envelope proteins, and will similarly infect susceptible cells. This article provides a partial review and some personal reflections of how these three viruses infect and of how recipient cells become susceptible, along with some consideration of questions that remain to be answered.

Entities:  

Keywords:  Entry; Envelope proteins; Hepatitis B virus; Hepatitis delta virus; Receptor

Mesh:

Substances:

Year:  2013        PMID: 24187448      PMCID: PMC3812472          DOI: 10.3748/wjg.v19.i40.6730

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.

Authors:  Marc Lütgehetmann; Lida V Mancke; Tassilo Volz; Martina Helbig; Lena Allweiss; Till Bornscheuer; Joerg M Pollok; Ansgar W Lohse; J Petersen; Stephan Urban; Maura Dandri
Journal:  Hepatology       Date:  2012-01-30       Impact factor: 17.425

2.  Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.

Authors:  Deborah J Watson; Gary P Kobinger; Marco A Passini; James M Wilson; John H Wolfe
Journal:  Mol Ther       Date:  2002-05       Impact factor: 11.454

3.  Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor.

Authors:  J S Li; S P Tong; J R Wands
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.

Authors:  Guocai Zhong; Huan Yan; Haimin Wang; Wenhui He; Zhiyi Jing; Yonghe Qi; Liran Fu; Zhenchao Gao; Yi Huang; Guangwei Xu; Xiaofeng Feng; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

5.  Primary human hepatocytes are susceptible to infection by hepatitis delta virus assembled with envelope proteins of woodchuck hepatitis virus.

Authors:  Severin Gudima; Yiping He; Ning Chai; Volker Bruss; Stephan Urban; William Mason; John Taylor
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

6.  Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration.

Authors:  P Gripon; C Diot; C Guguen-Guillouzo
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

7.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

8.  Role of glycosaminoglycans for binding and infection of hepatitis B virus.

Authors:  Corinna M Leistner; Stefanie Gruen-Bernhard; Dieter Glebe
Journal:  Cell Microbiol       Date:  2008-01       Impact factor: 3.715

9.  Proteoglycans act as cellular hepatitis delta virus attachment receptors.

Authors:  Oscar Lamas Longarela; Tobias T Schmidt; Katrin Schöneweis; Raffaella Romeo; Heiner Wedemeyer; Stephan Urban; Andreas Schulze
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  Getting to grips with hepatitis.

Authors:  Zhijian J Chen; Jin Ye
Journal:  Elife       Date:  2012-11-13       Impact factor: 8.140

View more
  6 in total

1.  A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Authors:  Manabu Kaneko; Koichi Watashi; Shinji Kamisuki; Hiroki Matsunaga; Masashi Iwamoto; Fumihiro Kawai; Hirofumi Ohashi; Senko Tsukuda; Satomi Shimura; Ryosuke Suzuki; Hideki Aizaki; Masaya Sugiyama; Sam-Yong Park; Takayoshi Ito; Naoko Ohtani; Fumio Sugawara; Yasuhito Tanaka; Masashi Mizokami; Camille Sureau; Takaji Wakita
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

2.  A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity.

Authors:  Junko S Takeuchi; Kento Fukano; Masashi Iwamoto; Senko Tsukuda; Ryosuke Suzuki; Hideki Aizaki; Masamichi Muramatsu; Takaji Wakita; Camille Sureau; Koichi Watashi
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

Review 3.  Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.

Authors:  Koichi Watashi; Takaji Wakita
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-03       Impact factor: 6.915

4.  Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.

Authors:  Satomi Shimura; Koichi Watashi; Kento Fukano; Michael Peel; Ann Sluder; Fumihiro Kawai; Masashi Iwamoto; Senko Tsukuda; Junko S Takeuchi; Takeshi Miyake; Masaya Sugiyama; Yuki Ogasawara; Sam-Yong Park; Yasuhito Tanaka; Hiroyuki Kusuhara; Masashi Mizokami; Camille Sureau; Takaji Wakita
Journal:  J Hepatol       Date:  2016-11-25       Impact factor: 25.083

Review 5.  NTCP and beyond: opening the door to unveil hepatitis B virus entry.

Authors:  Koichi Watashi; Stephan Urban; Wenhui Li; Takaji Wakita
Journal:  Int J Mol Sci       Date:  2014-02-19       Impact factor: 5.923

6.  The characteristic of the synonymous codon usage and phylogenetic analysis of hepatitis B virus.

Authors:  Xiaoming Qi; Chaojun Wei; Yonghong Li; Yu Wu; Hui Xu; Rui Guo; Yanjuan Jia; Zhenhao Li; Zhenhong Wei; Wanxia Wang; Jing Jia; Yuanting Li; Anqi Wang; Xiaoling Gao
Journal:  Genes Genomics       Date:  2020-05-27       Impact factor: 1.839

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.